Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam J Mufti

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Cancer Research|May 23, 2002
Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimerTerry J Gaymes, Ghulam J Mufti, Feyruz V Rassool
British Journal of Haematology|July 23, 2013
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromesAustin G Kulasekararaj, Azim M Mohamedali, Ghulam J Mufti
Haematologica|October 8, 2008
Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitorsTerry J Gaymes, Sydney Shall, Farzin Farzaneh, et al.
Cancer Gene Therapy|December 13, 2003
Role of 4-1BB:4-1BB ligand in cancer immunotherapyAdam T C Cheuk, Ghulam J Mufti, Barbara-ann Guinn
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 10, 2011
Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestationsEmma Craythorne, Anthony du Viver, Ghulam J Mufti, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 14, 2019
Clinical efficacy of rituximab in the treatment of pemphigus vulgaris: A 10-year follow-upZainab Laftah, Emma Craythorne, Ghulam J Mufti, et al.
Leukemia Research|October 5, 2002
Analysis of CHK2 in patients with myelodysplastic syndromesDilek Aktas, Matthew J Arno, Feyruz Rassool, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2019
The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic AnemiaJudith C W Marsh, Antonio M Risitano, Ghulam J Mufti
The New England Journal of Medicine|October 22, 2015
Somatic Mutations and Clonal Hematopoiesis in Aplastic AnemiaGhulam J Mufti, Austin G Kulasekararaj, Judith C W Marsh
Methods in Molecular Biology (Clifton, N.J.)|August 27, 2011
The use of PARP inhibitors in cancer therapy: use as adjuvant with chemotherapy or radiotherapy; use as a single agent in susceptible patients; techniques used to identify susceptible patientsSydney Shall, Terry Gaymes, Farzin Farzaneh, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Cancer Research|May 23, 2002
Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimerTerry J Gaymes, Ghulam J Mufti, Feyruz V Rassool
British Journal of Haematology|July 23, 2013
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromesAustin G Kulasekararaj, Azim M Mohamedali, Ghulam J Mufti
Haematologica|October 8, 2008
Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitorsTerry J Gaymes, Sydney Shall, Farzin Farzaneh, et al.
Cancer Gene Therapy|December 13, 2003
Role of 4-1BB:4-1BB ligand in cancer immunotherapyAdam T C Cheuk, Ghulam J Mufti, Barbara-ann Guinn
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 10, 2011
Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestationsEmma Craythorne, Anthony du Viver, Ghulam J Mufti, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 14, 2019
Clinical efficacy of rituximab in the treatment of pemphigus vulgaris: A 10-year follow-upZainab Laftah, Emma Craythorne, Ghulam J Mufti, et al.
Leukemia Research|October 5, 2002
Analysis of CHK2 in patients with myelodysplastic syndromesDilek Aktas, Matthew J Arno, Feyruz Rassool, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2019
The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic AnemiaJudith C W Marsh, Antonio M Risitano, Ghulam J Mufti
The New England Journal of Medicine|October 22, 2015
Somatic Mutations and Clonal Hematopoiesis in Aplastic AnemiaGhulam J Mufti, Austin G Kulasekararaj, Judith C W Marsh
Methods in Molecular Biology (Clifton, N.J.)|August 27, 2011
The use of PARP inhibitors in cancer therapy: use as adjuvant with chemotherapy or radiotherapy; use as a single agent in susceptible patients; techniques used to identify susceptible patientsSydney Shall, Terry Gaymes, Farzin Farzaneh, et al.
Pageof 23